Physician profile
Mark H Levy
NPI 1255433728
$5,002.96
in general payments reported to CMS, 2019-2025
44 companies · $455 in 2025
The $455 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $952 · 2020: $366 · 2021: $1,464 · 2022: $627 · 2023: $323 · 2024: $817 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,594.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,200.00 | 2021 | |
| Novo Nordisk INC | $896.42 | 2019-2022 | |
| Janssen Biotech, INC. | $586.20 | 2020-2025 | Erleada, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $574.64 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $147.47 | 2021-2025 | Provenge |
| Sumitomo Pharma America, INC. | $136.59 | 2023-2025 | Gemtesa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $105.69 | 2020 | |
| Antares Pharma, INC. | $101.83 | 2019-2025 | Xyosted |
| Takeda Pharmaceuticals U.S.A., INC. | $86.57 | 2019-2020 | |
| Abbvie INC. | $82.91 | 2022-2024 | |
| Boston Scientific Corporation | $78.69 | 2024-2025 | Spaceoar Vue System - 10ml, Rezum Generator, Lithovue Elite |
| Teva Pharmaceuticals USA, INC. | $69.49 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $62.23 | 2019 | |
| Lilly USA, LLC | $55.95 | 2019 | |
| Laborie Medical Technologies Corp. | $50.23 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.